ArticleThe Journal of clinical investigation2022

Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers.

Shion A Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.